Struggling to choose between DrugPatentWatch and WebMD? Both products offer unique advantages, making it a tough decision.
DrugPatentWatch is a Business & Commerce solution with tags like patents, drug-data, pharma-industry, drug-patents, patent-search.
It boasts features such as Searchable database of brand name, generic name, and ingredient drug patents, Patent expiry alerts and tracking, PDF copies of full text patents, International coverage including USA, Canada, Europe, Australia, and more, Search by patent assignee, inventor name, or patent number, Daily updated database, Archived copies of expired and abandoned patents and pros including Comprehensive database of pharmaceutical patents, Convenient search and tracking tools, PDF access to full patents, Global patent coverage, Frequent updates, Useful for competitive intelligence, Low cost compared to alternatives.
On the other hand, WebMD is a Sport & Health product tagged with medical, health, wellness, symptoms, conditions.
Its standout features include Symptom checker, Drug and treatment search, First aid information, Local health listings, Health and wellness articles, Interactive tools and quizzes, and it shines with pros like Reputable source of health information, Easy to navigate interface, Comprehensive health content, Available in mobile app.
To help you make an informed decision, we've compiled a comprehensive comparison of these two products, delving into their features, pros, cons, pricing, and more. Get ready to explore the nuances that set them apart and determine which one is the perfect fit for your requirements.
DrugPatentWatch is a database of pharmaceutical patents and expirations. It allows users to search for drug patents by brand name, generic name, company, expiry date, and other fields. The database covers patents in the USA, Canada, Europe, and more.
WebMD is an online publisher of news and information pertaining to human health and well-being. It provides reliable content including peer-reviewed articles, news, tools and symptom checkers to a general readership.